News

Lokavant will provide performance data on global trial sites and principal investigators.

Survey among readers evaluates the trajectory of RWD and how it can be more widely adopted.

Krka to use upgraded Calyx RIM, now on Microsoft Azure, for an additional five years.

Patients in all studies can consent to longitudinal data use to accelerate RWE

Two independent, publicly-traded companies will result upon completion.

Cancer Moonshot Biobank relies on Medidata's eConsent and EDC platforms.

Audio and video recording and compliance enhancements among new changes to platform.

Howard University College of Pharmacy will now offer a two-year post-professional Doctorate in Pharmacy fellowship program.

Partnership to enable AI-enhanced medical imaging services for CNS clinical trials.

Partnership will expand Sharp's reach to China.

Partnership to expand availability of clinical trials to over 20 hospitals and medical sites.

Service will utilize blockchain technology and enable certification of key documents.

The latest business and people happenings from the last month, all in one place.

DHA's PTSD Drug Treatment Program will deploy AiCure's adherence and digital biomarker solutions.

Why oncology needs dosing redesign.

RTSM solution now offers additional benefits with the delivery of study supplies to patients' homes.

CRO gains access to genetic testing data and aims to improve global research.

Pandemic has brought new sense of awareness to respiratory diseases and clinops.

More studies added to Clariness' patient recruitment platform.

Contest seeks to advance diversity and awareness in clinical trials.

UK-based patient recruitment company expands to North America with new office location in Raleigh, NC.

10 health technology innovators join the network and will help in creating new digital endpoints.

High-speed blister packaging line installed at clinical supply facility in Shiga, Japan.

Enhancements to Medidata Detect and Rave CTMS will improve both data oversight and reporting for sponsors and CROs.

Study launch at Morehouse School of Medicine is part of a major expansion of Beacon of Hope.

New end-to-end services include endpoint design, algorithm validation, biostatistical analysis, and regulatory engagement.

Single, integrated solution to provide eCOA and eConsent technology.

Almost three in four (73%) oncology research executives plan to execute either a fully decentralized or hybrid clinical trial in the next 12 months.